169
Views
13
CrossRef citations to date
0
Altmetric
Editorial

Paediatric psychopharmacology: closing the gap between science and practice

Pages 523-525 | Published online: 24 Feb 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Oleg V Tcheremissine, Don R Cherek & Scott D Lane. (2004) Psychopharmacology of conduct disorder: current progress and future directions. Expert Opinion on Pharmacotherapy 5:5, pages 1109-1116.
Read now
Jes Gerlach. (2002) Improving Outcome in Schizophrenia: The Potential Importance of EPS and Neuroleptic Dysphoria. Annals of Clinical Psychiatry 14:1, pages 47-57.
Read now

Articles from other publishers (11)

Anne Katrine Pagsberg, Pia Jeppesen, Dea Gowers Klauber, Karsten Gjessing Jensen, Ditte Rudå, Marie Stentebjerg-Olesen, Peter Jantzen, Simone Rasmussen, Eva Ann-Sofie Saldeen, Maj-Britt Glenn Lauritsen, Niels Bilenberg, Anne Dorte Stenstrøm, Jesper Pedersen, Louise Nyvang, Sarah Madsen, Marlene B Lauritsen, Ditte Lammers Vernal, Per Hove Thomsen, Jakob Paludan, Thomas M Werge, Kristian Winge, Klaus Juul, Christian Gluud, Maria Skoog, Jørn Wetterslev, Jens Richardt M Jepsen, Christoph U Correll, Anders Fink-Jensen & Birgitte Fagerlund. (2014) Quetiapine versus aripiprazole in children and adolescents with psychosis - protocol for the randomised, blinded clinical Tolerability and Efficacy of Antipsychotics (TEA) trial. BMC Psychiatry 14:1.
Crossref
Robin Steinberg-Epstein, Teri Book & Sharon B. Wigal. (2011) Controversies Surrounding Pediatric Psychopharmacology. Advances in Pediatrics 58:1, pages 153-179.
Crossref
C. HawJ. Stubbs. (2009) Off-label psychotropic prescribing for young persons in medium security. Journal of Psychopharmacology 24:10, pages 1491-1498.
Crossref
Russell E. Scheffer. (2006) Psychopharmacology: Clinical Implications of Brain Neurochemistry. Pediatric Clinics of North America 53:4, pages 767-775.
Crossref
Oleg V Tcheremissine & Lori M Lieving. (2006) Pharmacological Aspects of the Treatment of Conduct Disorder in Children and Adolescents. CNS Drugs 20:7, pages 549-565.
Crossref
Kate Keenan. (2005) ANTIPSYCHOTICS IN DISRUPTIVE BEHAVIOR DISORDERS AND ADHD. Journal of the American Academy of Child & Adolescent Psychiatry 44:10, pages 969-970.
Crossref
Celso Arango, Mara Parellada & Dolores Maria Moreno. (2004) Clinical effectiveness of new generation antipsychotics in adolescent patients. European Neuropsychopharmacology 14, pages S471-S479.
Crossref
Ulrike Ebert. (2003) Characteristics of pharmacokinetics and pharmacodynamics in children. BMC News and views 3:S1.
Crossref
A. V. Kuchaeva, L. E. Ziganshina, K. K. Yakhin, L. M. Minnetdinova, F. F. Gatin & E. B. Mikhailova. (2003) Pharmacoepidemiologic usage analysis of neuroleptics for treating paranoid schizophrenia in psychiatry hospital. Neurology Bulletin XXXV:1-2, pages 39-43.
Crossref
Dave Coghill. (2002) Evidence-based psychopharmacology for children and adolescents. Current Opinion in Psychiatry 15:4, pages 361-368.
Crossref
Jacqueline A. Sparks. (2007) TAKING A STAND: CHALLENGING MEDICAL DISCOURSE. Journal of Marital and Family Therapy 28:1, pages 51-59.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.